FcγR | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

74 results for “FcγR”

Trials

View all 35 →

Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) Genotype

73 participants · First posted Oct 12, 2011

Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms

121 participants · First posted Apr 10, 2013

Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

75 participants · First posted Aug 24, 2016

Drugs

S-4321

VIB-9600

News

View all 30 →

Margetuximab Shows Promise as Alternative Therapy in HER2-Positive Advanced Breast Cancer

Fc-optimized GITR antibody boosts CD4 T cell–dendritic cell teamwork against tumors

International Consortium Develops Revolutionary Platform to Predict Human Antibody Drug Responses

Page 1 of 8